Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. The firm is winding up its operations. The firm is seeking to sell all of its clinical assets and programs. The firm has not generated any revenue.
Wall Street analistlerine göre, 4 analist Calithera Biosciences Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 0 güçlü al, 0 al, 3 tut, 1 sat ve 0 güçlü sat içermektedir